PUBLISHER: Grand View Research | PRODUCT CODE: 1511889
PUBLISHER: Grand View Research | PRODUCT CODE: 1511889
The global wound cleanser products market size is anticipated to reach USD 2.79 billion by 2030, exhibiting a CAGR of 4.69% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is driven by numerous factors such as increasing incidence of surgical site infection (SSIs), rising healthcare expenditure, and increasing geriatric population.
The market growth is significantly driven by the rising number of surgical site infections (SSIs). Patients undergoing surgery are at an increased risk of surgical site infections (SSIs), which can result in prolonged hospital stays, higher healthcare expenses, and even complications. As a result, healthcare professionals focus on strict infection control procedures, such as using effective wound-cleaning solutions to decrease the incidence of surgical site infections. The market for wound cleanser products is expected to develop as a result of the growing demand for advanced cleansers with antimicrobial properties and moderate but effective formulations from healthcare facilities that improve surgical results and reduce the risk of post-operative infections.
For instance, as per the article by Antimicrobial Resistance & Infection Control in 2022, a study was conducted to estimate SSIs associated with surgical wounds. It was found that, of 338 patients, tertiary hospitals performed 245 (72.5%) and secondary hospitals performed 93 (27.5%) surgical wound procedures for patients. Compared to clean-contaminated wounds, the prevalence of SSI was greater in contaminated wounds, approximately 43.6%. Thus, some of the major factors expected to drive market expansion over the forecast period include an increase in the incidence of traumatic wounds and an increase in the prevalence of SSI.
Additionally, the focus on preventive healthcare practices drives the demand for wound cleaner products. Increasing numbers of healthcare providers are discovering the importance of preventive measures in reducing the incidence of surgical site infections (SSIs), especially during high-risk surgical operations. To reduce the risk of infections, this shift towards preventative treatment involves using stringent wound care protocols, which may include the use of specialty cleansers. Due to this, wound care manufacturers focus on developing novel and effective cleanser formulas that are customized to meet the changing requirements of healthcare facilities. This helps maintain the industry's expansion driven by the rising number of surgical site infections.